Dr. Sorrell on Vitality Unfiltered with David J. Bauder, PA-C (November 2026, 34 min). His first appearance, on online testosterone clinics, is summarized in How to Vet an Online TRT Clinic.

Longevity has become an industry: peptides, supplements, wearables, biological-age tests, continuous glucose monitors, advanced blood panels, hormone optimization. The list grows every year. I joined David J. Bauder, PA-C, on his podcast Vitality Unfiltered to sort out which of these have good evidence behind them and which are getting ahead of it. This article is the written version of that conversation, with sources added.

What is longevity medicine?

To me it comes down to two things. The first is preventive care done more intentionally. Traditional primary care is supposed to prevent chronic disease, but it is rushed, and when I practiced in that system I saw how much chronic disease still slipped through. Longevity medicine uses more tools and more diagnostics to find problems earlier, whether that is metabolic disease, heart disease, cognitive decline or cancer. The earlier you catch something, the more you can do about it.

The second is the goal: more healthy years, not just more years. That is the difference between lifespan and healthspan. Most people don’t want to reach 100 if the last 20 years are spent debilitated by chronic disease. They would rather live to 80 or 90 and spend most of that time healthy, doing the things they love with the people they love. Those later years are built now, before chronic disease takes hold.

Start with the four foundations

People want to talk about peptides, stem cells and supplement stacks, and I understand why. But you won’t get much from any of them if the foundation isn’t in place. Four things have strong evidence, aren’t controversial, and are mostly free.

1. Diet

There is no single best diet. What we do know is that processed food and added sugar work against you, and the more of your diet comes from whole foods, the healthier you are likely to be.

2. Exercise, and VO2 max in particular

Exercise is tied to longer life, more healthy years and less chronic disease. In longevity medicine we pay special attention to VO2 max, your maximum aerobic capacity, which most wearables now estimate. The higher it is, the lower your risk. In a study of more than 122,000 adults who had treadmill testing, the least fit had about five times the risk of death of the fittest, and the benefit kept rising with no upper limit.1 More in VO2 max and grip strength and zone 2 training.

3. Sleep

Regular, quality sleep, with enough deep and REM sleep to recover, matters for both health and longevity. The relationship is U-shaped: consistently short sleep is linked with higher mortality, and so is routinely sleeping far more than normal, which can be a sign that something else is wrong.2 There is a sweet spot in the middle, about 7 to 9 hours for most adults.

4. Stress management

This one gets the least attention, and it deserves more. Many people normalize stress and say they’re fine. When we look at the autonomic nervous system, for example with heart rate variability, we often see the stress side running high anyway. Unmanaged chronic stress feeds into worse health over time. More in Your Nervous System Is Aging You.

These four have more impact on your health and longevity than any supplement or peptide stack. They also compound. A celebrity with a dietitian, a chef and a personal trainer gets a different result from the same medication than someone who orders it online and changes nothing else. You don’t need that support team, but each small piece you add makes the others work better.

GLP-1 medications and muscle loss

GLP-1 medications such as semaglutide and tirzepatide help many people lose a lot of weight, improve blood sugar and insulin resistance, and shed visceral fat. Those are real gains. But part of the weight lost is lean mass, and muscle matters for longevity: it drives insulin sensitivity, strength and independence. Some people who lose weight quickly on these drugs end up looking gaunt rather than healthy.

The bigger concern is what happens after stopping. Many people regain weight. In the STEP 1 trial extension, people regained about two-thirds of the weight they had lost within a year of stopping semaglutide.3 If the fat comes back and the muscle doesn’t, someone can end up at their old weight with less muscle than before, which may leave them worse off than when they started.

We don’t yet know what that means 20 or 30 years out. Researchers take the problem seriously enough to test drugs that preserve muscle alongside GLP-1s: in a phase 2 trial, adding the investigational antibody bimagrumab to semaglutide shifted weight loss heavily toward fat.4 Bimagrumab is not approved. For now, the practical answer is to protect muscle while you’re on these medications: resistance training, enough protein, and tracking body composition with DEXA rather than the scale alone. More in You Lost 40 Pounds. How Much Was Muscle?

Peptides: promising, not proven

I’m open to peptides, with clear eyes about the evidence. There is research on many of them, but very little randomized trial data, and most will never get a large drug-company trial. So we work with what exists: smaller studies and a large body of anecdotal experience. That experience is mostly positive for some recovery peptides, some body-composition peptides, and some immune and cognitive peptides, and side effects tend to be mild.

I tell patients to think of peptides as helpers, not game-changers. Used for a specific goal and monitored, they can help you get where you’re going. They won’t turn anyone into Superman. Every peptide decision starts with an honest risk-benefit conversation, because these are still partly experimental.

Source matters as much as the molecule. I only use peptides from legitimate, accredited compounding pharmacies, and I don’t recommend “research peptides” bought online, where you can’t be sure what is in the vial. The regulatory picture has been shifting (background in The Peptide Dam May Be Breaking), but being available from a compounding pharmacy is not the same as FDA approval.

Better data is starting to come. The University of Arkansas has registered a small placebo-controlled pilot trial of BPC-157 after rotator cuff repair surgery, with 30 planned participants; it is not yet recruiting.5 Small academic studies like that are realistically how this field will get safety and efficacy data. How I approach peptide care is laid out in Peptide Doctor.

The advanced tests I find most useful

More testing is not automatically better medicine. The value is in knowing what to do with the result. These are the tests I order most often because they tend to change decisions:

  • A fuller hormone and thyroid picture. Not just TSH but the full thyroid panel, and not just estrogen, progesterone and testosterone but DHEA and pregnenolone too.
  • Cortisol across the day. Healthy cortisol rises in the morning and falls through the day. A single reading misses people whose levels stay high all day, or whose curve has flattened. Seeing the whole day shows the effect of chronic stress and guides what to do about it. See DUTCH testing and high cortisol symptoms.
  • Cardiovascular markers beyond the lipid panel. Lp(a), ApoB, LDL particle size, HDL detail and inflammatory markers.
  • Insulin, not just glucose. A fasting insulin paired with a fasting glucose gives a HOMA-IR score; the higher it is, the more insulin resistant you are. For a closer look, a one- or two-hour oral glucose tolerance test with insulin shows how your body handles a sugar load.
  • Genetics. We’re all dealt a hand at birth, and it helps to know what it is. Genetics can explain why your cholesterol runs high, how your body processes certain compounds, and your inherited risk of dementia and heart disease.
  • Mitochondrial testing. Newer, and still on the frontier. Mitochondria make the energy your cells run on, so damage there affects almost everything. I have found these tests helpful for targeting mitochondrial support, with the caveat that the evidence is young.

Biological-age tests: interesting, not always actionable

I have run a lot of biological-age tests with patients: an overall biological age, organ-system ages, pace of aging. Patients find them fascinating, and a result showing one system aging faster can be the push someone needs to take, say, their cardiovascular health seriously. But the result doesn’t tell you how to fix it. It points in a direction; it is not a plan. The plan still comes from the labs, imaging and history that explain why a system is aging faster. For an example of what these clocks can and can’t show, see Do GLP-1s Slow Aging?

Calcium score or coronary CT angiography?

A coronary artery calcium (CAC) score sees only calcified, “hard” plaque. Coronary CT angiography (CCTA) shows hard plaque and non-calcified “soft” plaque. When I want a real look at someone’s coronary arteries, I lean toward CCTA, because a low calcium score can give a false sense of security.

The data support both halves of that. In the Miami Heart Study, which scanned 2,359 adults without symptoms, 16% of people with a calcium score of zero still had plaque on CCTA. Severe disease was rare in that group, though: only 0.8% had a narrowing of 50% or more.6 So a zero score is reassuring about near-term risk, but it doesn’t mean plaque-free. CCTA does involve contrast dye and some radiation, which is part of the decision.

A carotid ultrasound is another easy option: no radiation and no contrast, and it can show early thickening or plaque in the neck arteries. How these fit together is in the Cardiovascular Risk Assessment guide.

What telemedicine can and can’t do

My practice is 100% telemedicine. For the work described here, that isn’t a limitation: a longevity workup is mostly labs, a DEXA scan, genetics and putting the pieces together, and none of that requires being in the same room. An acute problem, or anything that needs a physical exam, should be seen in person by a physician who can examine you. I’m not trying to replace that. Sorrell MD is licensed in Texas and most other U.S. states; contact the practice for the current list.

The bottom line

Longevity medicine is not about chasing the newest therapy. Get the foundations right, use testing that changes decisions, protect your muscle, and treat experimental options as experiments: discussed honestly, sourced properly and monitored. If you want help building that plan, read how the Comprehensive Longevity Program works, or start with a free 30-minute discovery call.

Frequently asked questions

What is longevity medicine?

Preventive care done more intentionally: using more detailed labs, imaging and genetics to find metabolic disease, heart disease, cognitive decline and cancer risk earlier, with the goal of extending healthspan, the years you live healthy, rather than lifespan alone.

What has the strongest evidence for longevity?

The basics: a mostly whole-food diet low in processed food and added sugar, regular exercise that raises VO2 max, consistent quality sleep, and stress management. They have more impact than any supplement or peptide, and most of them are free.

Do you lose muscle on a GLP-1 like semaglutide?

Part of the weight lost on GLP-1 medications is lean mass. Resistance training, adequate protein and tracking body composition with DEXA help protect muscle. Muscle matters even more if the medication is later stopped, because regained weight tends to come back without the muscle.

Are peptides like BPC-157 proven to work?

No. There are few randomized human trials, and most of the experience is anecdotal. Small academic trials, such as a planned University of Arkansas pilot after rotator cuff repair, are starting. If you consider peptides, use a physician and a licensed compounding pharmacy, not research peptides sold online.

Are biological-age tests worth it?

They can be motivating and can point to a system that is aging faster, but they rarely tell you what to change. Labs, imaging and history are what turn that signal into a plan.

Is a coronary calcium score of zero enough?

A zero score is reassuring about near-term risk, but it does not rule out plaque. In the Miami Heart Study, 16% of adults with a calcium score of zero had non-calcified plaque on coronary CT angiography, although severe narrowing was rare (0.8%).

References

  1. Mandsager K, Harb S, Cremer P, et al. “Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing.” JAMA Network Open (2018). DOI: 10.1001/jamanetworkopen.2018.3605

  2. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. “Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies.” Sleep (2010). DOI: 10.1093/sleep/33.5.585

  3. Wilding JPH, Batterham RL, Davies M, et al. “Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension.” Diabetes, Obesity and Metabolism (2022). DOI: 10.1111/dom.14725

  4. Heymsfield SB, et al. “Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial.” Nature Medicine (2026). DOI: 10.1038/s41591-026-04204-0

  5. University of Arkansas. “Impact of BPC-157 on Recovery From Rotator Cuff Repair Surgery.” ClinicalTrials.gov NCT07803250 (not yet recruiting as of November 2026). clinicaltrials.gov

  6. Nasir K, Cainzos-Achirica M, Valero-Elizondo J, et al. “Coronary atherosclerosis in an asymptomatic U.S. population: Miami Heart Study at Baptist Health South Florida.” JACC: Cardiovascular Imaging (2022). DOI: 10.1016/j.jcmg.2022.03.010

  7. Vitality Unfiltered with David J. Bauder, PA-C. “Longevity Medicine: What Really Works vs. What’s Hype? | Dr. Luke Sorrell.” November 9, 2026. youtube.com